Wednesday 20th April 2016 9:30 am to 6:30 pm
The Møller Centre, Churchill College, Cambridge CB3 0DE
This one-day conference will address the issues of evaluating early stage technology to optimise its chance of commercial success. Having a strong champion for the technology is a necessary but not sufficient requirement for commercial success. The conference will focus on tools and techniques to assess:
 |
Health care economics, essential for biopharma and medtech |
|
Project risks: converting risk to probability |
|
IP position: freedom to operate; IP protection available |
|
competition: competitive analysis; opportunity for disruption |
|
finance: valuation; is it investable? |
In addition, speakers from industry, consulting and VC will give their own perspective on technology evaluation. Ultimately, the evaluation process leads to a decision: to commercialise or not? The conference will conclude with a review of the psychology of decsion making, and the innate biases which affect those decisions.
Who should attend?
This Conference will be of value to everyone who has the responsibility for evaluating new technology from a strategic perspective: innovation and R&D managers; technology transfer executives; CEOs, COOs, and CTOs of early stage technology companies; strategy and technology managers in large corporates; licensing executives; professional advisors to technology based businesses.